Literature DB >> 21057331

Late diagnosis of developmental dysplasia of the hip: an analysis of risk factors.

Thomas Azzopardi1, Phillipa Van Essen, Peter J Cundy, Graeme Tucker, Annabelle Chan.   

Abstract

A neonatal clinical screening program for developmental dysplasia of the hip (DDH) operates in South Australia to diagnose DDH as early as possible. However, some cases of DDH are diagnosed late (>3 months of age). The aims of this study were to identify the specific risk factors for late diagnosis by comparing early diagnosed DDH, late diagnosed DDH, and normal controls in the South Australian population. There were 1945 children with DDH born between 1988 and 2003, of which 67 cases were late diagnosis (3.4%). Maternal characteristics, pregnancy, and delivery details were analyzed, and compared with controls (early diagnosed DDH and the general population). There was a trimodal pattern of age at presentation with a gradual increase in the incidence of late diagnosed DDH over the time period in this study. Birthweight (<2500 g), birth in a rural setting, and early hospital discharge following delivery (<4 days) were significant risk factors for late diagnosed DDH. Breech presentation and delivery by caesarean section were protective for late diagnosed DDH. Risk factors for late diagnosed DDH relate to factors that influence the screening program. A rigorous population-based hip surveillance program is important for early diagnosis of DDH.

Entities:  

Mesh:

Year:  2011        PMID: 21057331     DOI: 10.1097/BPB.0b013e3283415927

Source DB:  PubMed          Journal:  J Pediatr Orthop B        ISSN: 1060-152X            Impact factor:   1.041


  8 in total

1.  What Risk Factors and Characteristics Are Associated With Late-presenting Dislocations of the Hip in Infants?

Authors:  Kishore Mulpuri; Emily K Schaeffer; Janice Andrade; Wudbhav N Sankar; Nicole Williams; Travis H Matheney; Scott J Mubarak; Peter J Cundy; Charles T Price
Journal:  Clin Orthop Relat Res       Date:  2016-05       Impact factor: 4.176

2.  What Is the Impact of Center Variability in a Multicenter International Prospective Observational Study on Developmental Dysplasia of the Hip?

Authors:  Kishore Mulpuri; Emily K Schaeffer; Simon P Kelley; Pablo Castañeda; Nicholas M P Clarke; Jose A Herrera-Soto; Vidyadhar Upasani; Unni G Narayanan; Charles T Price
Journal:  Clin Orthop Relat Res       Date:  2016-05       Impact factor: 4.176

3.  Prevalence of developmental dysplasia of the hip in preterm infants with maternal risk factors.

Authors:  Cenk Sezer; Serhan Unlu; Ismail Demirkale; Murat Altay; Safa Kapicioglu; Murat Bozkurt
Journal:  J Child Orthop       Date:  2013-05-18       Impact factor: 1.548

Review 4.  Early dynamic ultrasound for neonatal hip instability: implications for rural Australia.

Authors:  Susan L Charlton; Adrian Schoo; Lucie Walters
Journal:  BMC Pediatr       Date:  2017-03-21       Impact factor: 2.125

5.  Patient factors associated with delayed diagnosis of developmental dysplasia of the hip.

Authors:  A W Lindberg; V Bompadre; E K Satchell; A C R Larson; K K White
Journal:  J Child Orthop       Date:  2017-06-01       Impact factor: 1.548

6.  Incidence of Neonatal Developmental Dysplasia of the Hip and Late Detection Rates Based on Screening Strategy: A Systematic Review and Meta-analysis.

Authors:  Ilari Kuitunen; Mikko M Uimonen; Marjut Haapanen; Reijo Sund; Ilkka Helenius; Ville T Ponkilainen
Journal:  JAMA Netw Open       Date:  2022-08-01

7.  Establishment of pediatric developmental dysplasia of the hip biobank: Shanghai children's hospital experience.

Authors:  Dan Yang; Shiqi Wang; Chenghui Ke; Qichao Ma; Lingyan Fan; Yichen Wang; Mengjie Chen; Hao Ying; Sun Wang; Qin Jiao; Yang Shen; Lihua Zhao
Journal:  Cell Tissue Bank       Date:  2022-02-25       Impact factor: 1.752

8.  Late-presenting developmental dysplasia of the hip in Jordanian males. A retrospective hospital based study.

Authors:  Omar Q Samarah; Fadi A Al Hadidi; Mohammad Q Hamdan; Ashraf T Hantouly
Journal:  Saudi Med J       Date:  2016-02       Impact factor: 1.484

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.